Home Sailing Initiative: Synthetic Biology Special Session Investment Roadshow to Explore China's Path of Original Innovation in Synthetic Biology

Sailing Initiative: Synthetic Biology Special Session Investment Roadshow to Explore China's Path of Original Innovation in Synthetic Biology

May 28, 2023 08:00 CST Updated 08:00

In recent years, the biotechnology and health industry has experienced rapid growth. The Chinese government has placed significant emphasis on fostering innovation within medical enterprises, issuing a series of policy guidelines to further standardize the market, encourage investment, and promote technological innovation. Driven by these policies and enhanced corporate innovation capabilities, innovative medical companies with independent intellectual property rights are emerging at an accelerated pace in China.

 

As an emerging force in the scientific community, synthetic biology is advancing rapidly and has demonstrated broad application prospects in fields such as medical aesthetics, pharmaceuticals, materials, agriculture, environment, and health. Currently, synthetic biology is moving toward fundamental technological innovation. Practitioners are carefully reconsidering and revolutionizing key issues such as product selection, mass production, and patenting, thereby establishing a productization mechanism that seamlessly integrates laboratory research achievements with standardized factory production. This will accelerate the commercialization of research outcomes and promote the healthy development of the industry.

 

As a leading hub for the development of synthetic biology in China, Shenzhen demonstrates absolute advantages in scientific research atmosphere, industrial environment, development policies, and supporting infrastructure, serving as a core force in driving source innovation in the country’s synthetic biology sector.

 

In this context[Synthetic Biology] Special Investment and Financing Roadshow, guided by the Science and Technology Innovation Bureau of Guangming District, Shenzhen; hosted by the Industrial Park Business Division of China Merchants Shekou; organized by China Merchants Shekou Innovation Center and VCBeat; and co-organized by China Merchants Smart CityYuMay 31, 14:00, officially held in Shenzhen.


Roadshow of 9 Synthetic Biology Companies

Executives from synthetic biology companies—including Jinkun Biotech, Hesheng Gene, Huamai Medical, Hedu Biotech, Weimiao Biotech, Youxin Hesheng, Trautec Medical, Xiangpeng Biotech, and Microstructure Factory—delivered roadshow presentations and engaged in interactive discussions with senior executives from more than 20 investment institutions on site.


1 Roundtable Discussion

Park Leaders, Corporate Representatives, and Investment Institutions Jointly Explore “The Path to Source Innovation in China’s Synthetic Biology”


0526更新新.jpg


Event Registration:This event will be held as an offline roadshow, with attendance limited to 80 participants.


Registration Method:http://hdxu.cn/lRqqa or scan the QR code on the poster to register.


Organizer Introduction


>>>>

China Merchants Shekou


China Merchants Shekou Industrial Zone Holdings Co., Ltd., established in 1979, specializes in the development and operation of industrial parks. It has deployed three major product lines across China: Wanggu, Yiku, and Smart City. The company holds 4.75 million square meters of industrial park assets, comprising a total of 25 park projects. Adhering to the full value chain of “integration, investment, construction, management, and exit” for park development and operations, the company implements precise, tailored strategies (“one park, one policy”) for its 25 parks nationwide. It is committed to building core competencies in spatial planning, industrial organization, ecosystem operation, innovation incubation, and industry-finance integration.

 

Leveraging its comprehensive advantages in development models, asset scale, industrial operations, industry cultivation, and innovation incubation, China Merchants Shekou Industrial Parks have garnered widespread market recognition, with their brand influence ranking among the industry leaders.

 

China Merchants Shekou’s industrial parks will next focus on building fourth-generation parks anchored in digital and low-carbon operations, enhancing the “INPARK” digital operation service platform by integrating the park BI system, industrial management system, smart operation system, and smart service system to empower the growth of tenant enterprises. Meanwhile, the industrial parks will position their business as “regional development enablers, comprehensive operation service providers, and innovators driving industrial advancement,” with the vision of becoming “leaders in the integrated development of cities and industries.” By proactively aligning with the national 14th Five-Year Plan strategy and closely linking national needs with China Merchants’ capabilities, they will lead industrial upgrading, consumption upgrading, and urban upgrading in the areas where each park is located, thereby fulfilling China Merchants Shekou’s vision and mission as an “enabler of better lives.”


>>>>

VCBeat


VCBeat, founded in 2014, is a novel industry service provider that leverages data as its foundation, research as its core, and brand media as its connector to facilitate the precise aggregation of industrial resources and accelerate the growth of industry innovators. It offers services such as brand communication, research consulting, data monitoring, and resource/project matchmaking to enterprises, government industrial parks, investment institutions, and other stakeholders across the industry chain.